Patents by Inventor Arnold Kriegstein

Arnold Kriegstein has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Ameliorating nervous systems disorders
    Patent number: 11564949
    Abstract: The present disclosure provides methods for the treatment of a mammal having a neurological condition, disease, or injury. The methods involve increasing the number of functional GABAergic interneurons at or near the site of the neurological disease, injury, or condition.
    Type: Grant
    Filed: August 14, 2020
    Date of Patent: January 31, 2023
    Assignee: The Regents of the University of California
    Inventors: Arnold Kriegstein, John L. R. Rubenstein, Scott C. Baraban, Arturo Alvarez-Buylla
  • Ameliorating Nervous Systems Disorders
    Publication number: 20210060082
    Abstract: The present disclosure provides methods for the treatment of a mammal having a neurological condition, disease, or injury.
    Type: Application
    Filed: August 14, 2020
    Publication date: March 4, 2021
    Inventors: Arnold Kriegstein, John L. R. Rubenstein, Scott C. Baraban, Arturo Alvarez-Buylla
  • Ameliorating nervous systems disorders
    Patent number: 10780131
    Abstract: The present disclosure provides methods for the treatment of a mammal having a neurological condition, disease, or injury. The methods involve increasing the number of functional GABAergic interneurons at or near the site of the neurological disease, injury, or condition.
    Type: Grant
    Filed: September 27, 2018
    Date of Patent: September 22, 2020
    Assignee: The Regents of the University of California
    Inventors: Arnold Kriegstein, John L. R. Rubenstein, Scott C. Baraban, Arturo Alvarez-Buylla
  • Ameliorating nervous systems disorders
    Patent number: 10206953
    Abstract: The present disclosure provides methods for the treatment of a mammal having a neurological condition, disease, or injury. The methods involve increasing the number of functional GABAergic interneurons at or near the site of the neurological disease, injury, or condition.
    Type: Grant
    Filed: November 17, 2015
    Date of Patent: February 19, 2019
    Assignee: The Regents of the University of California
    Inventors: Arnold Kriegstein, John L. R. Rubenstein, Scott C. Baraban, Arturo Alvarez-Buylla
  • Ameliorating Nervous Systems Disorders
    Publication number: 20190030084
    Abstract: The present disclosure provides methods for the treatment of a mammal having a neurological condition, disease, or injury.
    Type: Application
    Filed: September 27, 2018
    Publication date: January 31, 2019
    Inventors: Arnold Kriegstein, John L. R. Rubenstein, Scott C. Baraban, Arturo Alvarez-Buylla
  • Brain-specific enhancers for cell-based therapy
    Patent number: 9952216
    Abstract: Herein are described a set of novel specific human enhancers for specific forebrain cell types used to study and select for human neural progenitor cells. This approach enables the ability to generate interneurons from human ES, iPS and iN cells, making them available for human transplantation and for molecular/cellular analyzes. These approaches are also directly applicable to generating other neuronal cell types, such as cortical and striatal projection neurons, which have implications for many human diseases.
    Type: Grant
    Filed: October 10, 2014
    Date of Patent: April 24, 2018
    Assignee: The Regents of the University of California
    Inventors: Axel Visel, John L. R. Rubenstein, Ying-Jiun (Jasmine) Chen, Len A. Pennacchio, Daniel Vogt, Cory Nicholas, Arnold Kriegstein
  • Ameliorating Nervous Systems Disorders
    Publication number: 20160113969
    Abstract: The present disclosure provides methods for the treatment of a mammal having a neurological condition, disease, or injury.
    Type: Application
    Filed: November 17, 2015
    Publication date: April 28, 2016
    Inventors: Arnold Kriegstein, John L. R. Rubenstein, Scott C. Baraban, Arturo Alvarez-Buylla
  • Ameliorating nervous systems disorders
    Patent number: 9220729
    Abstract: The present disclosure provides methods for the treatment of a mammal having a neurological condition, disease, or injury. The methods involve increasing the number of functional GABAergic interneurons at or near the site of the neurological disease, injury, or condition.
    Type: Grant
    Filed: January 17, 2013
    Date of Patent: December 29, 2015
    Assignee: The Regents of the University of California
    Inventors: Arnold Kriegstein, John L. R. Rubenstein, Scott C. Baraban, Arturo Alvarez-Buylla
  • Ameliorating Nervous Systems Disorders
    Publication number: 20110165129
    Abstract: The present disclosure provides methods for the treatment of a mammal having a neurological condition, disease, or injury. The methods involve increasing the number of functional GABAergic interneurons at or near the site of the neurological disease, injury, or condition.
    Type: Application
    Filed: May 5, 2009
    Publication date: July 7, 2011
    Inventors: Arnold Kriegstein, John L.R. Rubenstein, Scott C. Baraban, Arturo Alvarez-Buylla